Skip to Main Content

Paper Details

Rationale and design of the AXIOMATIC-SSP phase II trial: Antithrombotic treatment with factor XIa inhibition to Optimize Management of Acute Thromboembolic events for Secondary Stroke Prevention.
J Stroke Cerebrovasc Dis
22
2022
Author NameAffiliation
Scott E KasnerHospital of the University of Pennsylvania
Georgios TsivgoulisNational and Kapodistrian University of Athens, Attikon University Hospital
  • 1 - 2

Datasets

Release 1.2